Cargando…

Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug

Detalles Bibliográficos
Autor principal: Ranganath, VK
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834165/
http://dx.doi.org/10.1186/ar1687
_version_ 1782178556424486912
author Ranganath, VK
author_facet Ranganath, VK
author_sort Ranganath, VK
collection PubMed
description
format Text
id pubmed-2834165
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28341652010-03-08 Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug Ranganath, VK Arthritis Res Ther Poster Presentation BioMed Central 2005 2005-02-17 /pmc/articles/PMC2834165/ http://dx.doi.org/10.1186/ar1687 Text en Copyright ©2005 BioMed Central Ltd
spellingShingle Poster Presentation
Ranganath, VK
Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
title Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
title_full Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
title_fullStr Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
title_full_unstemmed Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
title_short Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
title_sort characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834165/
http://dx.doi.org/10.1186/ar1687
work_keys_str_mv AT ranganathvk characteristicsandoutcomesinseropositivelateonsetrheumatoidarthritispatientswhostartanewdiseasemodifyingantirheumaticdrug